Endocrine Abstracts

The concurrence of glucose intolerance, hypertension, dyslipidemia and obesity has been termed metabolic syndrome. Each component of the metabolic syndrome is an independent risk factor for cardiovascular disease and diabetes type 2, the combination of these risk factors elevating the rates and severity of cardiac pathology.The therapeutic use of irbesartan, a selective blocker of the AT1 receptors, administered in arterial hypertension, coronary heart d...

The prevalence of depressive symptoms in patients suffering from type 2 diabetes is commonly acknowledged. Even mild depression is recognized as clinically relevant for the general health outcomes in this vulnerable patient group. Research in this area has been focused on biochemical markers reflecting common pathological processes of insulin resistance, inflammation and oxidative damage, all being assumed to be interconnected in both diabetes and depression. Most of the studi...